Heinz-Josef Lenz, MD | Authors


Nivolumab/Ipilimumab Combination Data Promising in MSI-H/dMMR mCRC

August 27, 2019

Heinz-Josef Lenz, MD, discusses the significance of the latest updates in the CheckMate 142 trial exploring an immunotherapy treatment combination in patients with metastatic colorectal cancer whose tumors are microsatellite instability–high or mismatch repair deficient.